9/12
04:07 pm
onct
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its "market perform" rating re-affirmed by analysts at Northland Securities. They now have a $2.00 price target on the stock.
High
Report
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its "market perform" rating re-affirmed by analysts at Northland Securities. They now have a $2.00 price target on the stock.